NRTI use linked to risk for primary open-angle glaucoma
Use of nucleoside and nucleotide reverse transcriptase inhibitors (NRTIs) is associated with an increased risk for primary open-angle glaucoma (POAG), according to a study published online June 20 in Ophthalmology.
Jul 8, 2025
0
13









